About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Psychiatry
›
top-articles
Department of Psychiatry
535
(top 1%)
papers
26.7K
(top 1%)
citations
81
(top 1%)
h
-index
146
(top 1%)
g
-index
571
all documents
28.6K
doc citations
3.7K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
The NIMH-MATRICS Consensus Statement on Negative Symptoms
Schizophrenia Bulletin
2006
1,081
2
Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity
Journal of Sleep Research
2000
914
3
Common genetic variants influence human subcortical brain structures
Nature
2015
772
4
The Brief Negative Symptom Scale: Psychometric Properties
Schizophrenia Bulletin
2011
653
5
Mechanisms of ketamine action as an antidepressant
Molecular Psychiatry
2018
646
6
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
Schizophrenia Bulletin
2004
538
7
Prevalence and Correlates of Diabetes in National Schizophrenia Samples
Schizophrenia Bulletin
2000
520
8
Brain Morphology and Schizophrenia
Archives of General Psychiatry
1992
496
9
Decisional Capacity for Informed Consent in Schizophrenia Research
Archives of General Psychiatry
2000
438
10
Association of depression with 10-year poststroke mortality
American Journal of Psychiatry
1993
429
11
Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes
Schizophrenia Research
1999
428
12
Ketamine activates psychosis and alters limbic blood flow in schizophrenia
NeuroReport
1995
423
13
Persistent Negative Symptoms in Schizophrenia: An Overview
Schizophrenia Bulletin
2007
366
14
Improving Employment Outcomes for Persons With Severe Mental Illnesses
Archives of General Psychiatry
2002
332
15
Progress in achieving quantitative classification of psychopathology
World Psychiatry
2018
329
16
The Mouse Forced Swim Test
Journal of Visualized Experiments
2011
316
17
The Association of Medical Comorbidity in Schizophrenia with Poor Physical and Mental Health
Journal of Nervous and Mental Disease
1999
313
18
The Tail Suspension Test
Journal of Visualized Experiments
2011
312
19
Children of Substance Abusers: Overview of Research Findings
Pediatrics
1999
293
20
Neurophysiological biomarkers for drug development in schizophrenia
Nature Reviews Drug Discovery
2008
283
21
Measures of quality of life among persons with severe and persistent mental disorders
Social Psychiatry and Psychiatric Epidemiology
1996
269
22
Children of substance abusers: overview of research findings
Pediatrics
1999
265
23
Cognitive Correlates of Job Tenure Among Patients With Severe Mental Illness
American Journal of Psychiatry
2002
258
24
Structural abnormalities in deficit and nondeficit schizophrenia
American Journal of Psychiatry
1993
243
25
Significance and Meaning of Neurological Signs in Schizophrenia: Two Decades Later
Schizophrenia Bulletin
2005
240
26
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease
Progress in Neurobiology
2012
236
27
Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia
Schizophrenia Research
2005
235
28
Assertive Community Treatment: Twenty-Five Years of Gold
Psychiatric Services
2000
219
29
Expanded School Mental Health Services
1997
217
30
Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder
Brain, Behavior, and Immunity
2011
211
31
Reduction of Endogenous Kynurenic Acid Formation Enhances Extracellular Glutamate, Hippocampal Plasticity, and Cognitive Behavior
Neuropsychopharmacology
2010
187
32
Racial Divergence in Adiposity During Adolescence: The NHLBI Growth and Health Study
Pediatrics
2001
183
33
The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities
Neuropsychopharmacology
2008
183
34
Assessment of depression prevalence in rural Uganda using symptom and function criteria
Social Psychiatry and Psychiatric Epidemiology
2004
179
35
Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
American Journal of Psychiatry
2008
161
36
Religiosity and religious obsessions in obsessive–compulsive disorder
Psychiatry Research
2001
155
37
A developmental sex difference in hippocampal neurogenesis is mediated by endogenous oestradiol
Biology of Sex Differences
2010
155
38
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum
World Psychiatry
2020
154
39
A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder
Psychiatry Research - Neuroimaging
2001
149
40
Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City
Drug and Alcohol Dependence
2016
146
41
Forty Years of Engagement Research in Children’s Mental Health Services: Multidimensional Measurement and Practice Elements
Journal of Clinical Child and Adolescent Psychology
2018
143
42
Neuropsychology of the Deficit Syndrome: New Data and Meta-analysis of Findings To Date
Schizophrenia Bulletin
2007
142
43
An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
Translational Psychiatry
2016
141
44
Antenatal prediction of postpartum depression with blood DNA methylation biomarkers
Molecular Psychiatry
2014
139
45
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects
NeuroImage
2003
138
46
Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory
Neuropsychopharmacology
2011
137
47
Convergent validation of quality of life assessments for persons with severe mental illnesses
Quality of Life Research
1993
136
48
Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Neuropsychopharmacology
2008
135
49
Neural structures underlying set-shifting: Roles of medial prefrontal cortex and anterior cingulate cortex
Behavioural Brain Research
2013
134
50
Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat
Neuropsychopharmacology
2003
133
site/software ©
exaly
; All materials licenced under
CC by-SA
.